KEGG   PATHWAY: mbez05017
Entry
mbez05017                   Pathway                                
Name
Spinocerebellar ataxia - Moschus berezovskii (Chinese forest musk deer)
Description
The autosomal dominant spinocerebellar ataxias (SCAs) are a group of progressive neurodegenerative diseases characterised by loss of balance and motor coordination due to the primary dysfunction of the cerebellum. Compelling evidence points to major aetiological roles for transcriptional dysregulation, protein aggregation and clearance, autophagy, the ubiquitin-proteasome system, alterations of calcium homeostasis, mitochondria defects, toxic RNA gain-of-function mechanisms and eventual cell death with apoptotic features of neurons during SCA disease progression.
Class
Human Diseases; Neurodegenerative disease
Pathway map
mbez05017  Spinocerebellar ataxia
mbez05017

Organism
Moschus berezovskii (Chinese forest musk deer) [GN:mbez]
Gene
129542690  TRPC3; short transient receptor potential channel 3 isoform X1 [KO:K04966]
129561218  GRM1; metabotropic glutamate receptor 1 [KO:K04603]
129556766  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
129548814  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 isoform X1 [KO:K05858] [EC:3.1.4.11]
129563187  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
129556526  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
129556560  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
129544793  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
129545462  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
129546400  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
129559020  GRIA1; glutamate receptor 1 isoform X1 [KO:K05197]
129542260  GRIA2; glutamate receptor 2 [KO:K05198]
129564201  GRIA3; glutamate receptor 3 [KO:K05199]
129559399  CACNA1A; voltage-dependent P/Q-type calcium channel subunit alpha-1A [KO:K04344]
129548039  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
129536224  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959]
129543844  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1 [KO:K04960]
129542563  ATXN2; ataxin-2 isoform X1 [KO:K23625]
129545487  ATXN2L; ataxin-2-like protein isoform X1 [KO:K23625]
129550588  ATXN3; ataxin-3 isoform X1 [KO:K11863] [EC:3.4.22.-]
129546860  RYR1; ryanodine receptor 1 isoform X1 [KO:K04961]
129560687  PDYN; proenkephalin-B [KO:K15840]
129539066  GRIN1; glutamate receptor ionotropic, NMDA 1 [KO:K05208]
129545368  GRIN2A; glutamate receptor ionotropic, NMDA 2A [KO:K05209]
129536255  GRIN2B; glutamate receptor ionotropic, NMDA 2B [KO:K05210]
129538079  GRIN2C; glutamate receptor ionotropic, NMDA 2C isoform X1 [KO:K05211]
129546598  GRIN2D; glutamate receptor ionotropic, NMDA 2D [KO:K05212]
129558929  GRIN3B; glutamate receptor ionotropic, NMDA 3B [KO:K05214]
129555725  MCU; calcium uniporter protein, mitochondrial isoform X1 [KO:K20858]
129558217  VDAC1; voltage-dependent anion-selective channel protein 1 [KO:K05862]
129555687  VDAC2; voltage-dependent anion-selective channel protein 2 [KO:K15040]
129549434  VDAC3; voltage-dependent anion-selective channel protein 3 [KO:K15041]
129560157  voltage-dependent anion-selective channel protein 3-like [KO:K15041]
129562882  voltage-dependent anion-selective channel protein 3-like [KO:K15041]
129542617  SLC25A31; ADP/ATP translocase 4 [KO:K05863]
129549309  SLC25A4; ADP/ATP translocase 1 [KO:K05863]
129564629  SLC25A6; ADP/ATP translocase 3 [KO:K05863]
129535024  SLC25A5; ADP/ATP translocase 2 [KO:K05863]
129555671  PPIF; peptidyl-prolyl cis-trans isomerase F, mitochondrial [KO:K09565] [EC:5.2.1.8]
129536239  cytochrome c-like [KO:K08738]
129538389  cytochrome c 2 [KO:K08738]
129552526  cytochrome c [KO:K08738]
129549799  AFG3L2; AFG3-like protein 2 isoform X1 [KO:K08956] [EC:3.4.24.-]
129547147  AFG3-like protein 1 isoform X1 [KO:K08956] [EC:3.4.24.-]
129540924  OMA1; metalloendopeptidase OMA1, mitochondrial isoform X1 [KO:K23010] [EC:3.4.24.-]
129544313  OPA1; dynamin-like 120 kDa protein, mitochondrial isoform X1 [KO:K17079] [EC:3.6.5.5]
129556483  FGF14; fibroblast growth factor 14 isoform X1 [KO:K23920]
129548715  SPTBN2; spectrin beta chain, non-erythrocytic 2 isoform X1 [KO:K23932]
129550517  PSMA6; proteasome subunit alpha type-6 [KO:K02730] [EC:3.4.25.1]
129552575  PSMA2; proteasome subunit alpha type-2 [KO:K02726] [EC:3.4.25.1]
129550408  PSMA4; proteasome subunit alpha type-4 [KO:K02728] [EC:3.4.25.1]
129549718  PSMA8; proteasome subunit alpha-type 8 [KO:K02731] [EC:3.4.25.1]
129561363  PSMA7; proteasome subunit alpha type-7 [KO:K02731] [EC:3.4.25.1]
129541114  PSMA5; proteasome subunit alpha type-5 [KO:K02729] [EC:3.4.25.1]
129554486  PSMA1; proteasome subunit alpha type-1 [KO:K02725] [EC:3.4.25.1]
129562420  PSMA3; proteasome subunit alpha type-3 isoform X1 [KO:K02727] [EC:3.4.25.1]
129562506  proteasome subunit alpha type-3-like [KO:K02727] [EC:3.4.25.1]
129537072  PSMB6; proteasome subunit beta type-6 [KO:K02738] [EC:3.4.25.1]
129539899  PSMB7; proteasome subunit beta type-7 [KO:K02739] [EC:3.4.25.1]
129544336  PSMB3; proteasome subunit beta type-3 [KO:K02735] [EC:3.4.25.1]
129540914  PSMB2; proteasome subunit beta type-2 [KO:K02734] [EC:3.4.25.1]
129562452  PSMB5; proteasome subunit beta type-5 [KO:K02737] [EC:3.4.25.1]
129560868  PSMB1; proteasome subunit beta type-1 [KO:K02732] [EC:3.4.25.1]
129540647  PSMB4; proteasome subunit beta type-4 [KO:K02736] [EC:3.4.25.1]
129552369  PSMC2; 26S proteasome regulatory subunit 7 [KO:K03061]
129562511  PSMC1; 26S proteasome regulatory subunit 4 [KO:K03062]
129546821  PSMC4; 26S proteasome regulatory subunit 6B [KO:K03063]
129562650  PSMC6; 26S proteasome regulatory subunit 10B [KO:K03064]
129554823  PSMC3; 26S proteasome regulatory subunit 6A [KO:K03065]
129544542  PSMC5; 26S proteasome regulatory subunit 8 isoform X1 [KO:K03066]
129545229  PSMD2; 26S proteasome non-ATPase regulatory subunit 2 [KO:K03028]
129538585  PSMD1; 26S proteasome non-ATPase regulatory subunit 1 [KO:K03032]
129544367  PSMD3; 26S proteasome non-ATPase regulatory subunit 3 [KO:K03033]
129542628  PSMD9; 26S proteasome non-ATPase regulatory subunit 9 [KO:K06693]
129544562  PSMD12; 26S proteasome non-ATPase regulatory subunit 12 [KO:K03035]
129540095  PSMD11; 26S proteasome non-ATPase regulatory subunit 11 [KO:K03036]
129547987  PSMD6; 26S proteasome non-ATPase regulatory subunit 6 [KO:K03037]
129546950  PSMD7; 26S proteasome non-ATPase regulatory subunit 7 [KO:K03038]
129548583  PSMD13; 26S proteasome non-ATPase regulatory subunit 13 [KO:K03039]
129549582  LOW QUALITY PROTEIN: 26S proteasome non-ATPase regulatory subunit 4-like [KO:K03029]
129548374  LOW QUALITY PROTEIN: 26S proteasome non-ATPase regulatory subunit 4-like [KO:K03029]
129537555  PSMD14; 26S proteasome non-ATPase regulatory subunit 14 [KO:K03030]
129546868  PSMD8; 26S proteasome non-ATPase regulatory subunit 8 [KO:K03031]
129561284  ADRM1; proteasomal ubiquitin receptor ADRM1 isoform X1 [KO:K06691]
129544549  ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]
129539173  TRAF2; TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
129560696  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
129559467  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
129561625  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
129555633  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
129543668  ATXN1; ataxin-1 isoform X1 [KO:K23616]
129546937  ATXN1L; ataxin-1-like [KO:K23616]
129548763  KAT5; histone acetyltransferase KAT5 isoform X1 [KO:K11304] [EC:2.3.1.48]
129563280  RORA; nuclear receptor ROR-alpha isoform X1 [KO:K08532]
129542629  ATP2A2; sarcoplasmic/endoplasmic reticulum calcium ATPase 2 isoform X1 [KO:K05853] [EC:7.2.2.10]
129545483  ATP2A1; sarcoplasmic/endoplasmic reticulum calcium ATPase 1 [KO:K05853] [EC:7.2.2.10]
129541748  ATP2A3; sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform X1 [KO:K05853] [EC:7.2.2.10]
129558683  SLC1A6; excitatory amino acid transporter 4 [KO:K05617]
129546770  CIC; protein capicua homolog isoform X1 [KO:K20225]
129538656  PUM1; pumilio homolog 1 isoform X1 [KO:K17943]
129539876  PUM2; pumilio homolog 2 isoform X1 [KO:K17943]
129563183  TBPL2; TATA box-binding protein-like 2 [KO:K03120]
129539720  TATA-box-binding protein-like [KO:K03120]
129560719  TBPL1; TATA box-binding protein-like 1 [KO:K03120]
129560866  TBP; TATA-box-binding protein [KO:K03120]
129564112  RBPJL; recombining binding protein suppressor of hairless-like protein isoform X1 [KO:K06053]
129561785  RBPJ; recombining binding protein suppressor of hairless isoform X1 [KO:K06053]
129535764  SP1; transcription factor Sp1 [KO:K04684]
129535942  transcription initiation factor IIB-like [KO:K03124]
129541840  GTF2B; transcription initiation factor IIB isoform X1 [KO:K03124]
129543383  NFYA; nuclear transcription factor Y subunit alpha isoform X1 [KO:K08064]
129542397  XBP1; LOW QUALITY PROTEIN: X-box-binding protein 1 [KO:K09027]
129553792  MYOD1; myoblast determination protein 1 [KO:K09064]
129551531  MTOR; serine/threonine-protein kinase mTOR isoform X1 [KO:K07203] [EC:2.7.11.1]
129542526  ULK1; serine/threonine-protein kinase ULK1 [KO:K21357] [EC:2.7.11.1]
129544195  ULK2; serine/threonine-protein kinase ULK2 isoform X1 [KO:K08269] [EC:2.7.11.1]
129535748  ATG101; autophagy-related protein 101 isoform X1 [KO:K19730]
129554798  ATG13; autophagy-related protein 13 isoform X1 [KO:K08331]
129559855  RB1CC1; RB1-inducible coiled-coil protein 1 [KO:K17589]
129554797  AMBRA1; activating molecule in BECN1-regulated autophagy protein 1 isoform X1 [KO:K17985]
129550493  LOW QUALITY PROTEIN: beclin-1-like [KO:K08334]
129551103  BECN2; beclin-2 [KO:K08334]
129544444  BECN1; beclin-1 [KO:K08334]
129552091  beclin-2-like [KO:K08334]
129540359  beclin-2-like [KO:K08334]
129549374  PIK3R4; phosphoinositide 3-kinase regulatory subunit 4 isoform X1 [KO:K08333] [EC:2.7.11.1]
129563556  ATG14; beclin 1-associated autophagy-related key regulator [KO:K17889]
129555797  NRBF2; nuclear receptor-binding factor 2 [KO:K21246]
129549677  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]
129548797  ATG2A; autophagy-related protein 2 homolog A [KO:K17906]
129550628  ATG2B; autophagy-related protein 2 homolog B isoform X1 [KO:K17906]
129544785  WIPI1; WD repeat domain phosphoinositide-interacting protein 1 isoform X1 [KO:K17908]
129545777  WIPI2; WD repeat domain phosphoinositide-interacting protein 2 [KO:K17908]
129546434  KCNC3; potassium voltage-gated channel subfamily C member 3 [KO:K04889]
129541724  KCND3; potassium voltage-gated channel subfamily D member 3 isoform X1 [KO:K04893]
129552370  RELN; reelin [KO:K06249] [EC:3.4.21.-]
129557617  VLDLR; very low-density lipoprotein receptor isoform X1 [KO:K20053]
129541029  DAB1; disabled homolog 1 isoform X1 [KO:K20054]
129551508  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
129547146  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
129559156  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
129553207  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha [KO:K02649]
129540801  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
129550706  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
129551602  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
129546814  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
129555437  TWNK; twinkle mtDNA helicase [KO:K17680] [EC:5.6.2.3]
129537192  ATXN10; ataxin-10 isoform X1 [KO:K19323]
129560622  NOP56; nucleolar protein 56 [KO:K14564]
Compound
C00025  L-Glutamate
C00076  Calcium cation
C00165  Diacylglycerol
C00238  Potassium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
Reference
  Authors
Matilla-Duenas A, Sanchez I, Corral-Juan M, Davalos A, Alvarez R, Latorre P
  Title
Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
  Journal
Cerebellum 9:148-66 (2010)
DOI:10.1007/s12311-009-0144-2
Reference
  Authors
Duenas AM, Goold R, Giunti P
  Title
Molecular pathogenesis of spinocerebellar ataxias.
  Journal
Brain 129:1357-70 (2006)
DOI:10.1093/brain/awl081
Reference
  Authors
Mark MD, Schwitalla JC, Groemmke M, Herlitze S
  Title
Keeping Our Calcium in Balance to Maintain Our Balance.
  Journal
Biochem Biophys Res Commun 483:1040-1050 (2017)
DOI:10.1016/j.bbrc.2016.07.020
Reference
  Authors
Egorova PA, Bezprozvanny IB
  Title
Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.
  Journal
FEBS J 285:3547-3565 (2018)
DOI:10.1111/febs.14366
Reference
  Authors
Shimobayashi E, Kapfhammer JP
  Title
Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
  Journal
Curr Neuropharmacol 16:151-159 (2018)
DOI:10.2174/1570159X15666170529104000
Reference
  Authors
Kasumu A, Bezprozvanny I
  Title
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
  Journal
Cerebellum 11:630-9 (2012)
DOI:10.1007/s12311-010-0182-9
Reference
  Authors
Egorova P, Popugaeva E, Bezprozvanny I
  Title
Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.
  Journal
Semin Cell Dev Biol 40:127-33 (2015)
DOI:10.1016/j.semcdb.2015.03.010
Reference
  Authors
Hisatsune C, Hamada K, Mikoshiba K
  Title
Ca(2+) signaling and spinocerebellar ataxia.
  Journal
Biochim Biophys Acta Mol Cell Res 1865:1733-1744 (2018)
DOI:10.1016/j.bbamcr.2018.05.009
Reference
  Authors
Takada SH, Ikebara JM, de Sousa E, Cardoso DS, Resende RR, Ulrich H, Ruckl M, Rudiger S, Kihara AH
  Title
Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.
  Journal
Mol Neurobiol 54:6870-6884 (2017)
DOI:10.1007/s12035-016-0205-8
Reference
  Authors
Brown SA, Loew LM
  Title
Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.
  Journal
Front Neurosci 8:453 (2014)
DOI:10.3389/fnins.2014.00453
Reference
  Authors
Inoue T
  Title
Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.
  Journal
Keio J Med 52:244-9 (2003)
DOI:10.2302/kjm.52.244
Reference
  Authors
Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N
  Title
Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.
  Journal
J Biol Chem 283:19854-63 (2008)
DOI:10.1074/jbc.M801492200
Reference
  Authors
Smeets CJ, Jezierska J, Watanabe H, Duarri A, Fokkens MR, Meijer M, Zhou Q, Yakovleva T, Boddeke E, den Dunnen W, van Deursen J, Bakalkin G, Kampinga HH, van de Sluis B, Verbeek DS
  Title
Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.
  Journal
Brain 138:2537-52 (2015)
DOI:10.1093/brain/awv195
Reference
  Authors
Tulli S, Del Bondio A, Baderna V, Mazza D, Codazzi F, Pierson TM, Ambrosi A, Nolte D, Goizet C, Toro C, Baets J, Deconinck T, DeJonghe P, Mandich P, Casari G, Maltecca F
  Title
Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
  Journal
J Med Genet 56:499-511 (2019)
DOI:10.1136/jmedgenet-2018-105766
Reference
  Authors
Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolo V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F
  Title
Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
  Journal
Neurobiol Dis 124:14-28 (2019)
DOI:10.1016/j.nbd.2018.10.018
Reference
  Authors
Becker EBE
  Title
From Mice to Men: TRPC3 in Cerebellar Ataxia.
  Journal
Cerebellum 16:877-879 (2017)
DOI:10.1007/s12311-015-0663-y
Reference
  Authors
Hoxha E, Tempia F, Lippiello P, Miniaci MC
  Title
Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.
  Journal
Front Synaptic Neurosci 8:35 (2016)
DOI:10.3389/fnsyn.2016.00035
Reference
  Authors
Yan H, Pablo JL, Pitt GS
  Title
FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
  Journal
Cell Rep 4:66-75 (2013)
DOI:10.1016/j.celrep.2013.06.012
Reference
  Authors
Tada M, Nishizawa M, Onodera O
  Title
Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.
  Journal
Neurochem Int 94:1-8 (2016)
DOI:10.1016/j.neuint.2016.01.007
Reference
  Authors
Pietrobon D
  Title
CaV2.1 channelopathies.
  Journal
Pflugers Arch 460:375-93 (2010)
DOI:10.1007/s00424-010-0802-8
Reference
  Authors
Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL 3rd, Lennon VA, Mori Y, Imoto K, Inuzuka T
  Title
Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.
  Journal
Neurobiol Dis 17:198-204 (2004)
DOI:10.1016/j.nbd.2004.07.013
Reference
  Authors
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H
  Title
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.
  Journal
Genes Dev 16:1345-55 (2002)
DOI:10.1101/gad.992302
Reference
  Authors
Evers MM, Toonen LJ, van Roon-Mom WM
  Title
Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
  Journal
Mol Neurobiol 49:1513-31 (2014)
DOI:10.1007/s12035-013-8596-2
Reference
  Authors
Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC
  Title
Polyglutamine tracts regulate autophagy.
  Journal
Autophagy 13:1613-1614 (2017)
DOI:10.1080/15548627.2017.1336278
Reference
  Authors
Chen RH, Chen YH, Huang TY
  Title
Ubiquitin-mediated regulation of autophagy.
  Journal
J Biomed Sci 26:80 (2019)
DOI:10.1186/s12929-019-0569-y
Reference
  Authors
Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT
  Title
RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
  Journal
Cell 127:697-708 (2006)
DOI:10.1016/j.cell.2006.09.036
Reference
  Authors
Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajic A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT
  Title
ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
  Journal
Neuron 97:1235-1243.e5 (2018)
DOI:10.1016/j.neuron.2018.02.013
Reference
  Authors
Jimenez G, Shvartsman SY, Paroush Z
  Title
The Capicua repressor--a general sensor of RTK signaling in development and disease.
  Journal
J Cell Sci 125:1383-91 (2012)
DOI:10.1242/jcs.092965
Reference
  Authors
Gennarino VA, Palmer EE, McDonell LM, Wang L, Adamski CJ, Koire A, See L, Chen CA, Schaaf CP, Rosenfeld JA, Panzer JA, Moog U, Hao S, Bye A, Kirk EP, Stankiewicz P, Breman AM, McBride A, Kandula T, Dubbs HA, Macintosh R, Cardamone M, Zhu Y, Ying K, Dias KR, Cho MT, Henderson LB, Baskin B, Morris P, Tao J, Cowley MJ, Dinger ME, Roscioli T, Caluseriu O, Suchowersky O, Sachdev RK, Lichtarge O, Tang J, Boycott KM, Holder JL Jr, Zoghbi HY
  Title
A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures.
  Journal
Cell 172:924-936.e11 (2018)
DOI:10.1016/j.cell.2018.02.006
Reference
  Authors
Irie T, Matsuzaki Y, Sekino Y, Hirai H
  Title
Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
  Journal
J Physiol 592:229-47 (2014)
DOI:10.1113/jphysiol.2013.264309
Reference
  Authors
Bushart DD, Murphy GG, Shakkottai VG
  Title
Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.
  Journal
Ann Transl Med 4:25 (2016)
DOI:10.3978/j.issn.2305-5839.2016.01.06
Reference
  Authors
Hsiao CT, Fu SJ, Liu YT, Lu YH, Zhong CY, Tang CY, Soong BW, Jeng CJ
  Title
Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.
  Journal
Hum Mutat 40:2088-2107 (2019)
DOI:10.1002/humu.23865
Reference
  Authors
Duarri A, Lin MC, Fokkens MR, Meijer M, Smeets CJ, Nibbeling EA, Boddeke E, Sinke RJ, Kampinga HH, Papazian DM, Verbeek DS
  Title
Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
  Journal
Cell Mol Life Sci 72:3387-99 (2015)
DOI:10.1007/s00018-015-1894-2
Reference
  Authors
Matilla-Duenas A, Volpini V
  Title
Spinocerebellar Ataxia Type 37
  Journal
GeneReviews (1993)
Reference
  Authors
Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Mendez-Del-Barrio C, Jesus S, Mir P, Volpini V, Alvarez-Ramo R, Sanchez I, Matilla-Duenas A
  Title
Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
  Journal
Brain 141:1981-1997 (2018)
DOI:10.1093/brain/awy137
Reference
  Authors
Swinnen B, Robberecht W, Van Den Bosch L
  Title
RNA toxicity in non-coding repeat expansion disorders.
  Journal
EMBO J e101112 (2019)
DOI:10.15252/embj.2018101112
Reference
  Authors
Ishikawa K, Nagai Y
  Title
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31).
  Journal
Neurotherapeutics 10.1007/s13311-019-00804-6 (2019)
DOI:10.1007/s13311-019-00804-6
Reference
  Authors
Niimi Y, Takahashi M, Sugawara E, Umeda S, Obayashi M, Sato N, Ishiguro T, Higashi M, Eishi Y, Mizusawa H, Ishikawa K
  Title
Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.
  Journal
Neuropathology 33:600-11 (2013)
DOI:10.1111/neup.12032
Reference
  Authors
Kobayashi H, Abe K, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, Habu T, Liu W, Okuda H, Koizumi A
  Title
Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.
  Journal
Am J Hum Genet 89:121-30 (2011)
DOI:10.1016/j.ajhg.2011.05.015
Related
pathway
mbez03050  Proteasome
mbez04020  Calcium signaling pathway
mbez04140  Autophagy - animal
mbez04141  Protein processing in endoplasmic reticulum
mbez04210  Apoptosis
mbez04724  Glutamatergic synapse
mbez04730  Long-term depression
KO pathway
ko05017   
LinkDB

DBGET integrated database retrieval system